Antila Generic Medicine Profile
Key Indicators
- Authorised Capital ₹ 90.00 K
- Paid Up Capital ₹ 90.00 K
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Antila Generic Medicine
Antila Generic Medicine Private Limited (AGMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 February 2021 (Three years and 11 months 16 days old ). Its registered office is in Goa, Goa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 90.00 K and a paid-up capital of Rs 90.00 K , as per Ministry of Corporate Affairs (MCA) records.
Shubhangi Naik and Anushka Naik serve as directors at the Company.
Company Details
-
Location
Goa, Goa, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300GA2021PTC014700
-
Company No.
014700
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Feb 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Antila Generic Medicine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhangi Naik
|
Director | 23-Feb-2021 | Current |
|
Anushka Naik
|
Director | 27-Sep-2022 | Current |
Financial Performance of Antila Generic Medicine.
Enhance accessibility to Antila Generic Medicine's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Antila Generic Medicine?
Unlock access to Antila Generic Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Antila Wealth LlpShubhangi Naik and Anushka Naik are mutual person
-
Antila Healthcare Llp
Shubhangi Naik and Anushka Naik are mutual person
-
Antila Lifestyle Private Limited
Shubhangi Naik and Anushka Naik are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Antila Generic Medicine?
Antila Generic Medicine has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antila Generic Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antila Generic Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
